MRONJ and Polynucleotides-Hyaluronic Acid Hydrogel (Regenfast®)

Key facts

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Principal Investigator

Carlo Lajolo

Fondazione Policlinico Universitario A. Gemelli, IRCCS

Intervention

MRONJ resection plus PN+HA(device)

Enrollment

10 enrolled

Eligibility

All sexes

Timeline

2025 – 2027

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Osteonecrosis

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNANCT07177378
  Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure
  Tanta University
• RECRUITINGNCT06420284
  Immunological Parameters Between MRONJ Stages
  Marmara University
• RECRUITINGNCT06430762
  Therapeutic Exposures and Risk Factors in MRONJ
  Marmara University
• RECRUITINGNANCT06129214
  Partial Synovectomy in Articular Side of Quadriceps Tendon Verified to Reduce Crepitus in Retrospective Study
  Gangnam Severance Hospital
• RECRUITINGPHASE2NCT05664815
  Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management
  Centre Hospitalier Universitaire de Besancon
• RECRUITINGNCT04098146
  Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis
  AO Innovation Translation Center
• RECRUITINGNCT06457776
  Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs
  Catholic University of the Sacred Heart
• ENROLLING BY INVITATIONNCT05329558
  Local and Systemic Changes in Osteonecrosis of the Jawbone
  Medical University of Graz

See all trials for Osteonecrosis →